Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Benign Prostatic Hyperplasia Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Benign Prostatic Hyperplasia Treatmentmarket, defines the market attractiveness level of Benign Prostatic Hyperplasia Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Benign Prostatic Hyperplasia Treatment industry, describes the types of Benign Prostatic Hyperplasia Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Benign Prostatic Hyperplasia Treatment market and the development prospects and opportunities of Benign Prostatic Hyperplasia Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Benign Prostatic Hyperplasia Treatment market in Chapter 13.
By Player:
Astellas Pharma
Teva Pharmaceutical Industries
GlaxoSmithKline
Boehringer Ingelheim GmbH
Merck
Urologix
LISA Laser
Asahi Kasei Corporation
Teleflex Incorporated
Abbott
Olympus
Boston Scientific Corporation
Allergan plc
Pfizer
Sanofi
Endo International
By Type:
Drug Class
Minimally Invasive Surgeries
Laser Therapy
Others
By End-User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Benign Prostatic Hyperplasia Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Benign Prostatic Hyperplasia Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Benign Prostatic Hyperplasia Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Benign Prostatic Hyperplasia Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Benign Prostatic Hyperplasia Treatment Market Analysis and Outlook to 2022
-
7.1 Global Benign Prostatic Hyperplasia Treatment Consumption (2017-2022)
-
7.2 United States Benign Prostatic Hyperplasia Treatment Consumption (2017-2022)
-
7.3 Europe Benign Prostatic Hyperplasia Treatment Consumption (2017-2022)
-
7.4 China Benign Prostatic Hyperplasia Treatment Consumption (2017-2022)
-
7.5 Japan Benign Prostatic Hyperplasia Treatment Consumption (2017-2022)
-
7.6 India Benign Prostatic Hyperplasia Treatment Consumption (2017-2022)
-
7.7 South Korea Benign Prostatic Hyperplasia Treatment Consumption (2017-2022)
8 Region and Country-wise Benign Prostatic Hyperplasia Treatment Market Analysis and Outlook to 2028
-
8.1 Global Benign Prostatic Hyperplasia Treatment Consumption Forecast (2022-2028)
-
8.2 United States Benign Prostatic Hyperplasia Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Benign Prostatic Hyperplasia Treatment Consumption Forecast (2022-2028)
-
8.4 China Benign Prostatic Hyperplasia Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Benign Prostatic Hyperplasia Treatment Consumption Forecast (2022-2028)
-
8.6 India Benign Prostatic Hyperplasia Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Benign Prostatic Hyperplasia Treatment Consumption Forecast (2022-2028)
9 Global Benign Prostatic Hyperplasia Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Benign Prostatic Hyperplasia Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Drug Class Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Minimally Invasive Surgeries Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Laser Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Benign Prostatic Hyperplasia Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Benign Prostatic Hyperplasia Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Benign Prostatic Hyperplasia Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Drug Class Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Minimally Invasive Surgeries Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Laser Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Benign Prostatic Hyperplasia Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Benign Prostatic Hyperplasia Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Benign Prostatic Hyperplasia Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Benign Prostatic Hyperplasia Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Benign Prostatic Hyperplasia Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Benign Prostatic Hyperplasia Treatment Market Competitive Analysis
-
14.1 Astellas Pharma
-
14.1.1 Astellas Pharma Company Details
-
14.1.2 Astellas Pharma Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Astellas Pharma Benign Prostatic Hyperplasia Treatment Product and Service
-
14.2 Teva Pharmaceutical Industries
-
14.2.1 Teva Pharmaceutical Industries Company Details
-
14.2.2 Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Product and Service
-
14.4 Boehringer Ingelheim GmbH
-
14.4.1 Boehringer Ingelheim GmbH Company Details
-
14.4.2 Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Benign Prostatic Hyperplasia Treatment Product and Service
-
14.6 Urologix
-
14.6.1 Urologix Company Details
-
14.6.2 Urologix Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Urologix Benign Prostatic Hyperplasia Treatment Product and Service
-
14.7 LISA Laser
-
14.7.1 LISA Laser Company Details
-
14.7.2 LISA Laser Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 LISA Laser Benign Prostatic Hyperplasia Treatment Product and Service
-
14.8 Asahi Kasei Corporation
-
14.8.1 Asahi Kasei Corporation Company Details
-
14.8.2 Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Product and Service
-
14.9 Teleflex Incorporated
-
14.9.1 Teleflex Incorporated Company Details
-
14.9.2 Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Product and Service
-
14.10 Abbott
-
14.10.1 Abbott Company Details
-
14.10.2 Abbott Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Abbott Benign Prostatic Hyperplasia Treatment Product and Service
-
14.11 Olympus
-
14.11.1 Olympus Company Details
-
14.11.2 Olympus Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Olympus Benign Prostatic Hyperplasia Treatment Product and Service
-
14.12 Boston Scientific Corporation
-
14.12.1 Boston Scientific Corporation Company Details
-
14.12.2 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Product and Service
-
14.13 Allergan plc
-
14.13.1 Allergan plc Company Details
-
14.13.2 Allergan plc Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Allergan plc Benign Prostatic Hyperplasia Treatment Product and Service
-
14.14 Pfizer
-
14.14.1 Pfizer Company Details
-
14.14.2 Pfizer Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Pfizer Benign Prostatic Hyperplasia Treatment Product and Service
-
14.15 Sanofi
-
14.15.1 Sanofi Company Details
-
14.15.2 Sanofi Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Sanofi Benign Prostatic Hyperplasia Treatment Product and Service
-
14.16 Endo International
-
14.16.1 Endo International Company Details
-
14.16.2 Endo International Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Endo International Benign Prostatic Hyperplasia Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Benign Prostatic Hyperplasia Treatment
-
Figure Benign Prostatic Hyperplasia Treatment Picture
-
Table Global Benign Prostatic Hyperplasia Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Benign Prostatic Hyperplasia Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Benign Prostatic Hyperplasia Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Benign Prostatic Hyperplasia Treatment Consumption by Country (2017-2022)
-
Figure United States Benign Prostatic Hyperplasia Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Benign Prostatic Hyperplasia Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Benign Prostatic Hyperplasia Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Benign Prostatic Hyperplasia Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Benign Prostatic Hyperplasia Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Benign Prostatic Hyperplasia Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Benign Prostatic Hyperplasia Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Benign Prostatic Hyperplasia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Benign Prostatic Hyperplasia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Benign Prostatic Hyperplasia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Benign Prostatic Hyperplasia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Benign Prostatic Hyperplasia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Benign Prostatic Hyperplasia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Class Consumption and Growth Rate (2017-2022)
-
Figure Global Minimally Invasive Surgeries Consumption and Growth Rate (2017-2022)
-
Figure Global Laser Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Class Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Minimally Invasive Surgeries Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Laser Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Benign Prostatic Hyperplasia Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Benign Prostatic Hyperplasia Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Urologix (Foundation Year, Company Profile and etc.)
-
Table Urologix Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Urologix Benign Prostatic Hyperplasia Treatment Product and Service
-
Table LISA Laser (Foundation Year, Company Profile and etc.)
-
Table LISA Laser Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table LISA Laser Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Asahi Kasei Corporation (Foundation Year, Company Profile and etc.)
-
Table Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Teleflex Incorporated (Foundation Year, Company Profile and etc.)
-
Table Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Olympus (Foundation Year, Company Profile and etc.)
-
Table Olympus Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Olympus Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Boston Scientific Corporation (Foundation Year, Company Profile and etc.)
-
Table Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Allergan plc (Foundation Year, Company Profile and etc.)
-
Table Allergan plc Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan plc Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Benign Prostatic Hyperplasia Treatment Product and Service
-
Table Endo International (Foundation Year, Company Profile and etc.)
-
Table Endo International Benign Prostatic Hyperplasia Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo International Benign Prostatic Hyperplasia Treatment Product and Service
-
